THALIDOMIDE

THALIDOMIDE was reported 36691 times

THALIDOMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACTINOMYCOTIC SEPSIS 17 0.6800
1 BLOOD HUMAN CHORIONIC GONADOTROPIN INCREASED 112 0.5258
2 BLOOD HUMAN CHORIONIC GONADOTROPIN ABNORMAL 16 0.4706
3 LEUKAEMIA PLASMACYTIC 45 0.2778
4 MYELOMA RECURRENCE 24 0.2400
5 TYPE 2 LEPRA REACTION 44 0.2353
6 MULTIPLE MYELOMA 855 0.1833
7 IVTH NERVE PARALYSIS 42 0.1772
8 PSEUDOMYOPIA 18 0.1552
9 MEDULLOBLASTOMA 20 0.1342
10 HEPATOSPLENIC T-CELL LYMPHOMA 44 0.1186
11 PLASMACYTOMA 212 0.1138
12 PLASMACYTOSIS 19 0.0995
13 WOUND DEBRIDEMENT 40 0.0957
14 PLASMA CELL LEUKAEMIA 55 0.0917
15 PLASMA CELL MYELOMA RECURRENT 297 0.0914
16 PLASMA CELL MYELOMA REFRACTORY 121 0.0904
17 COMPLICATIONS OF BONE MARROW TRANSPLANT 32 0.0886
18 NEUROPATHY 150 0.0882
19 BONE DEBRIDEMENT 42 0.0870
20 DENTAL TREATMENT 21 0.0868
21 REFRACTORY CANCER 18 0.0841
22 CARCINOMA 21 0.0778
23 ASEPTIC NECROSIS BONE 56 0.0716
24 PRIMARY SEQUESTRUM 64 0.0706
25 PREGNANCY OF PARTNER 49 0.0691
26 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 17 0.0627
27 MORGANELLA INFECTION 18 0.0614
28 PARAPROTEINAEMIA 18 0.0581
29 ACTINOMYCOSIS 53 0.0553
30 SEQUESTRECTOMY 36 0.0539
31 EXPOSURE VIA BODY FLUID 42 0.0534
32 HUMAN CHORIONIC GONADOTROPIN INCREASED 48 0.0530
33 PLASMA CELL MYELOMA 2058 0.0527
34 CONGENITAL APLASIA 16 0.0514
35 ORAL SOFT TISSUE DISORDER 17 0.0507
36 B-CELL TYPE ACUTE LEUKAEMIA 37 0.0504
37 RENAL CELL CARCINOMA STAGE UNSPECIFIED 28 0.0493
38 AMYLOIDOSIS 84 0.0487
39 CELLULITIS STAPHYLOCOCCAL 30 0.0461
40 TRANSMISSION OF DRUG VIA SEMEN 22 0.0456
41 BODY DYSMORPHIC DISORDER 17 0.0453
42 BONE LESION 163 0.0452
43 MONOCLONAL IMMUNOGLOBULIN PRESENT 31 0.0408
44 OSTEOLYSIS 81 0.0396
45 ENTEROCOCCAL SEPSIS 31 0.0383
46 LIGHT CHAIN ANALYSIS INCREASED 39 0.0378
47 LIFE EXPECTANCY SHORTENED 21 0.0370
48 GASTROINTESTINAL FUNGAL INFECTION 19 0.0369
49 VARICELLA ZOSTER VIRUS INFECTION 74 0.0357
50 JAW OPERATION 31 0.0349
51 INTERVERTEBRAL DISC SPACE NARROWING 28 0.0347
52 SINUS POLYP 20 0.0347
53 AORTIC CALCIFICATION 20 0.0344
54 CEREBRAL TOXOPLASMOSIS 32 0.0343
55 OSTEOSCLEROSIS 53 0.0336
56 FOCAL NODULAR HYPERPLASIA 17 0.0327
57 ACUTE LEUKAEMIA 52 0.0322
58 NO ADVERSE EFFECT 57 0.0315
59 GINGIVAL ULCERATION 23 0.0305
60 BLOOD IMMUNOGLOBULIN A INCREASED 16 0.0297
61 OSTEOMYELITIS CHRONIC 18 0.0291
62 ARACHNOIDITIS 20 0.0289
63 JC VIRUS INFECTION 46 0.0288
64 MONOCLONAL GAMMOPATHY 18 0.0287
65 METASTATIC MALIGNANT MELANOMA 65 0.0283
66 VERTEBRAL FORAMINAL STENOSIS 23 0.0279
67 PITTING OEDEMA 17 0.0278
68 GINGIVAL INFECTION 22 0.0274
69 EXCESSIVE GRANULATION TISSUE 22 0.0273
70 PERIPHERAL SENSORY NEUROPATHY 159 0.0272
71 ACUTE LYMPHOCYTIC LEUKAEMIA 76 0.0268
72 EXPOSED BONE IN JAW 57 0.0263
73 CARDIAC AMYLOIDOSIS 28 0.0254
74 ENDOCARDITIS BACTERIAL 20 0.0254
75 IGA NEPHROPATHY 42 0.0253
76 MYELOFIBROSIS 74 0.0244
77 STEM CELL TRANSPLANT 61 0.0244
78 SPINAL CORD COMPRESSION 95 0.0244
79 PERIPHERAL MOTOR NEUROPATHY 34 0.0243
80 POLYNEUROPATHY 290 0.0242
81 BLOOD IMMUNOGLOBULIN G INCREASED 27 0.0222
82 MUCOSAL EROSION 20 0.0220
83 ARRHYTHMIA SUPRAVENTRICULAR 24 0.0220
84 DIVERTICULAR PERFORATION 45 0.0218
85 INFECTION REACTIVATION 25 0.0218
86 ABSCESS JAW 22 0.0212
87 DISEASE PROGRESSION 2495 0.0211
88 PATHOLOGICAL FRACTURE 107 0.0211
89 KYPHOSIS 36 0.0204
90 BLOOD IMMUNOGLOBULIN M DECREASED 20 0.0199
91 BK VIRUS INFECTION 67 0.0198
92 VASCULAR CALCIFICATION 21 0.0197
93 NEUROPATHY PERIPHERAL 1829 0.0192
94 SICK SINUS SYNDROME 22 0.0191
95 PERIPHERAL SENSORIMOTOR NEUROPATHY 24 0.0191
96 OBLITERATIVE BRONCHIOLITIS 25 0.0190
97 ACUTE MYELOID LEUKAEMIA 293 0.0188
98 MYELODYSPLASTIC SYNDROME 270 0.0186
99 BONE SWELLING 18 0.0186
100 SQUAMOUS CELL CARCINOMA OF SKIN 112 0.0185
101 BACTERIAL SEPSIS 59 0.0181
102 RENAL FAILURE CHRONIC 139 0.0181
103 LEFT ATRIAL DILATATION 23 0.0180
104 AUTONOMIC NEUROPATHY 18 0.0178
105 EPSTEIN-BARR VIRAEMIA 19 0.0171
106 PERIODONTAL DISEASE 24 0.0171
107 OSTEITIS 43 0.0170
108 EMBOLISM VENOUS 51 0.0168
109 CATHETER RELATED INFECTION 17 0.0168
110 BONE DISORDER 300 0.0164
111 PARAINFLUENZAE VIRUS INFECTION 25 0.0164
112 LOBAR PNEUMONIA 30 0.0162
113 ENTEROCOCCAL BACTERAEMIA 17 0.0160
114 IMMUNOGLOBULINS DECREASED 22 0.0160
115 AORTIC ARTERIOSCLEROSIS 41 0.0159
116 CUSHINGOID 51 0.0159
117 PNEUMONIA PNEUMOCOCCAL 23 0.0155
118 STAPHYLOCOCCAL BACTERAEMIA 67 0.0154
119 DEVICE RELATED SEPSIS 31 0.0154
120 LUNG INFILTRATION 132 0.0149
121 CLOSTRIDIUM COLITIS 18 0.0148
122 PERIODONTITIS 32 0.0148
123 ATELECTASIS 141 0.0146
124 TOOTH EXTRACTION 181 0.0145
125 ORAL SURGERY 34 0.0145
126 SPONDYLOLISTHESIS 25 0.0144
127 ENTEROCOCCAL INFECTION 69 0.0143
128 SOFT TISSUE INFECTION 26 0.0142
129 FAILURE TO THRIVE 72 0.0139
130 OSTEONECROSIS 451 0.0137
131 LOOSE TOOTH 44 0.0136
132 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 29 0.0136
133 COMPRESSION FRACTURE 73 0.0136
134 SPINAL OSTEOARTHRITIS 117 0.0133
135 PROTEIN TOTAL INCREASED 35 0.0131
136 DEEP VEIN THROMBOSIS 844 0.0130
137 BLOOD IMMUNOGLOBULIN G DECREASED 32 0.0129
138 OSTEOMYELITIS 233 0.0129
139 BONE MARROW TRANSPLANT 24 0.0126
140 LYMPHOPENIA 177 0.0125
141 PNEUMONIA FUNGAL 49 0.0124
142 MASTICATION DISORDER 38 0.0124
143 STRONGYLOIDIASIS 20 0.0124
144 GRAFT VERSUS HOST DISEASE 89 0.0124
145 OSTEONECROSIS OF JAW 306 0.0124
146 CYTOMEGALOVIRUS CHORIORETINITIS 24 0.0123
147 JAW DISORDER 67 0.0122
148 HYPERCALCAEMIA 151 0.0122
149 INTERVERTEBRAL DISCITIS 23 0.0122
150 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 100 0.0121
151 JAW FRACTURE 26 0.0120
152 EMBOLISM 99 0.0119
153 CYSTITIS HAEMORRHAGIC 48 0.0119
154 GRAFT VERSUS HOST DISEASE IN SKIN 26 0.0118
155 NOCARDIOSIS 30 0.0117
156 ACUTE SINUSITIS 20 0.0116
157 PURULENT DISCHARGE 49 0.0115
158 DILATATION VENTRICULAR 24 0.0114
159 CYTOMEGALOVIRUS INFECTION REACTIVATION 50 0.0113
160 METASTATIC RENAL CELL CARCINOMA 20 0.0109
161 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 30 0.0108
162 HYPOGAMMAGLOBULINAEMIA 71 0.0108
163 SPINAL DEFORMITY 18 0.0107
164 ESCHERICHIA SEPSIS 31 0.0107
165 HAEMATOTOXICITY 101 0.0106
166 SPINAL COMPRESSION FRACTURE 86 0.0104
167 GINGIVITIS 56 0.0104
168 BLOOD CULTURE POSITIVE 31 0.0103
169 ARTERIAL THROMBOSIS 20 0.0103
170 LUMBAR SPINAL STENOSIS 30 0.0103
171 NEUROGENIC BLADDER 21 0.0099
172 PROTHROMBIN TIME PROLONGED 59 0.0099
173 THERAPY PARTIAL RESPONDER 152 0.0097
174 SECOND PRIMARY MALIGNANCY 81 0.0097
175 PSEUDOMONAL SEPSIS 17 0.0097
176 THROMBOPHLEBITIS 34 0.0097
177 BRONCHOPNEUMONIA 33 0.0096
178 ADENOCARCINOMA OF COLON 18 0.0096
179 PROSTATE CANCER METASTATIC 32 0.0096
180 RADICULOPATHY 25 0.0095
181 NEUTROPENIC SEPSIS 67 0.0094
182 GINGIVAL RECESSION 18 0.0094
183 PANCYTOPENIA 522 0.0093
184 AORTIC VALVE INCOMPETENCE 39 0.0092
185 BASAL CELL CARCINOMA 143 0.0092
186 HEPATITIS B 55 0.0091
187 MUCOSAL INFLAMMATION 238 0.0091
188 BLOOD ALBUMIN DECREASED 71 0.0089
189 ACTINIC KERATOSIS 23 0.0089
190 STREPTOCOCCAL INFECTION 49 0.0088
191 CACHEXIA 45 0.0087
192 BRAIN NEOPLASM MALIGNANT 39 0.0087
193 CARDIOPULMONARY FAILURE 34 0.0087
194 APLASIA 17 0.0087
195 LEFT VENTRICULAR HYPERTROPHY 37 0.0086
196 PNEUMOCYSTIS JIROVECI PNEUMONIA 19 0.0085
197 SPINAL COLUMN INJURY 19 0.0085
198 BACTERAEMIA 101 0.0085
199 VARICELLA 20 0.0084
200 MALIGNANT NEOPLASM PROGRESSION 857 0.0084
201 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 65 0.0084
202 FULL BLOOD COUNT DECREASED 168 0.0083
203 BONE MARROW FAILURE 169 0.0083
204 TRICUSPID VALVE INCOMPETENCE 66 0.0083
205 NO THERAPEUTIC RESPONSE 100 0.0082
206 HAEMATOCRIT DECREASED 162 0.0082
207 DIFFICULTY IN WALKING 28 0.0081
208 INTERVERTEBRAL DISC DEGENERATION 75 0.0081
209 GASTROINTESTINAL INFLAMMATION 63 0.0080
210 TUMOUR LYSIS SYNDROME 70 0.0079
211 BONE MARROW DISORDER 24 0.0079
212 THROMBOCYTOPENIA 884 0.0079
213 VENOUS THROMBOSIS 31 0.0079
214 SINUS BRADYCARDIA 76 0.0079
215 LEUKAEMIA 74 0.0078
216 GROWTH RETARDATION 23 0.0078
217 FIBROSIS 24 0.0078
218 ORAL FUNGAL INFECTION 21 0.0077
219 NEPHROGENIC SYSTEMIC FIBROSIS 23 0.0076
220 DECUBITUS ULCER 62 0.0076
221 PLATELET DISORDER 19 0.0075
222 DYSAESTHESIA 23 0.0075
223 STAPHYLOCOCCAL SEPSIS 37 0.0075
224 DEATH 6421 0.0074
225 ORAL INTAKE REDUCED 18 0.0074
226 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 71 0.0074
227 SPLENOMEGALY 87 0.0074
228 CARDIOMEGALY 91 0.0074
229 BRAIN HERNIATION 22 0.0074
230 SEPSIS 821 0.0074
231 DIVERTICULUM 52 0.0073
232 METASTASES TO CENTRAL NERVOUS SYSTEM 94 0.0073
233 MALIGNANT MELANOMA 97 0.0072
234 HYPOALBUMINAEMIA 56 0.0072
235 CHRONIC GRAFT VERSUS HOST DISEASE 26 0.0072
236 LARGE INTESTINE PERFORATION 50 0.0072
237 PSEUDOMONAS INFECTION 61 0.0071
238 GASTROINTESTINAL TOXICITY 34 0.0071
239 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 53 0.0071
240 ANOREXIA 91 0.0071
241 PAIN IN JAW 200 0.0071
242 HEPATOSPLENOMEGALY 18 0.0070
243 MITRAL VALVE INCOMPETENCE 79 0.0070
244 OSTEOPENIA 105 0.0069
245 SQUAMOUS CELL CARCINOMA 65 0.0069
246 RETROPERITONEAL HAEMORRHAGE 17 0.0069
247 PLEURITIC PAIN 19 0.0069
248 PULMONARY EMBOLISM 654 0.0069
249 FEBRILE NEUTROPENIA 455 0.0069
250 ORAL DISORDER 50 0.0068
251 RENAL CYST 54 0.0068
252 GINGIVAL SWELLING 30 0.0068
253 HYDROCEPHALUS 37 0.0068
254 BUNDLE BRANCH BLOCK RIGHT 31 0.0067
255 RED CELL DISTRIBUTION WIDTH INCREASED 28 0.0067
256 NEUROTOXICITY 118 0.0067
257 BLEPHARITIS 27 0.0067
258 PERFORMANCE STATUS DECREASED 31 0.0066
259 PROTEIN URINE PRESENT 33 0.0066
260 AORTIC STENOSIS 23 0.0066
261 ANXIETY DISORDER 22 0.0066
262 PARAPLEGIA 19 0.0066
263 INTERVERTEBRAL DISC DISORDER 28 0.0066
264 GINGIVAL DISORDER 25 0.0065
265 HEPATIC CYST 22 0.0065
266 MULTI-ORGAN FAILURE 112 0.0065
267 LUNG CONSOLIDATION 18 0.0064
268 SUDDEN DEATH 68 0.0064
269 JOINT EFFUSION 44 0.0064
270 HYPOPHOSPHATAEMIA 47 0.0064
271 METASTASIS 45 0.0063
272 RENAL FAILURE ACUTE 267 0.0063
273 ECCHYMOSIS 43 0.0063
274 AZOTAEMIA 25 0.0063
275 ENDOCARDITIS 32 0.0062
276 NEUTROPENIA 841 0.0062
277 SEPTIC SHOCK 269 0.0062
278 LUNG INFECTION 96 0.0062
279 PULMONARY HAEMORRHAGE 48 0.0061
280 CLOSTRIDIUM DIFFICILE COLITIS 65 0.0061
281 METASTATIC NEOPLASM 26 0.0060
282 HUMERUS FRACTURE 29 0.0060
283 CANDIDIASIS 24 0.0060
284 RESPIRATORY FAILURE 436 0.0060
285 HAEMATOLOGICAL MALIGNANCY 17 0.0060
286 ORTHOSTATIC HYPOTENSION 103 0.0059
287 DYSLIPIDAEMIA 30 0.0059
288 RENAL FAILURE 783 0.0059
289 BLOOD PHOSPHORUS INCREASED 16 0.0059
290 LUNG NEOPLASM 25 0.0058
291 PROTEIN TOTAL DECREASED 22 0.0058
292 FACET JOINT SYNDROME 19 0.0058
293 DIASTOLIC DYSFUNCTION 18 0.0058
294 ILEUS PARALYTIC 26 0.0058
295 TOOTH ABSCESS 59 0.0058
296 HYPOXIA 204 0.0058
297 MYOPATHY 50 0.0058
298 FISTULA 65 0.0058
299 OESOPHAGEAL CANDIDIASIS 23 0.0058
300 SPINAL COLUMN STENOSIS 27 0.0057
301 THROMBOTIC THROMBOCYTOPENIC PURPURA 20 0.0057
302 HEPATITIS B REACTIVATION 18 0.0057
303 METASTASES TO SPINE 19 0.0056
304 NON-SMALL CELL LUNG CANCER 27 0.0056
305 WOUND DEHISCENCE 19 0.0056
306 DENTAL CARIES 62 0.0056
307 DEFORMITY 52 0.0056
308 MALNUTRITION 62 0.0055
309 ADENOVIRUS INFECTION 16 0.0055
310 ATRIAL FLUTTER 44 0.0055
311 INFECTION 788 0.0054
312 INTESTINAL PERFORATION 61 0.0054
313 PLEURAL EFFUSION 329 0.0054
314 HYPOCALCAEMIA 102 0.0054
315 NECROTISING FASCIITIS 19 0.0054
316 THROMBOSIS 433 0.0054
317 ANAEMIA 1026 0.0054
318 PNEUMONIA 1716 0.0053
319 CYTOMEGALOVIRUS INFECTION 88 0.0053
320 PHLEBITIS 27 0.0053
321 DIVERTICULUM INTESTINAL 23 0.0053
322 CREATININE RENAL CLEARANCE DECREASED 21 0.0052
323 CEREBRAL ISCHAEMIA 27 0.0052
324 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 26 0.0052
325 INTERNATIONAL NORMALISED RATIO DECREASED 21 0.0052
326 ELECTROLYTE IMBALANCE 60 0.0052
327 CAROTID ARTERY STENOSIS 18 0.0051
328 ORAL INFECTION 20 0.0051
329 HYPERGLYCAEMIA 186 0.0051
330 UNEVALUABLE EVENT 385 0.0051
331 EXOSTOSIS 46 0.0050
332 HERPES ZOSTER 289 0.0050
333 CLOSTRIDIAL INFECTION 17 0.0050
334 ARTERIOSCLEROSIS 47 0.0050
335 BLOOD DISORDER 40 0.0050
336 SUDDEN CARDIAC DEATH 17 0.0050
337 ESCHERICHIA URINARY TRACT INFECTION 21 0.0049
338 IMPAIRED HEALING 161 0.0049
339 ACUTE RESPIRATORY DISTRESS SYNDROME 86 0.0049
340 HAEMOGLOBIN DECREASED 498 0.0048
341 BENIGN PROSTATIC HYPERPLASIA 25 0.0048
342 OEDEMA PERIPHERAL 590 0.0048
343 CARDIAC FAILURE CONGESTIVE 388 0.0048
344 LUMBAR VERTEBRAL FRACTURE 22 0.0048
345 CONGESTIVE CARDIOMYOPATHY 20 0.0048
346 DERMATITIS EXFOLIATIVE 24 0.0048
347 MENTAL STATUS CHANGES 133 0.0048
348 GUILLAIN-BARRE SYNDROME 23 0.0048
349 DECREASED INTEREST 28 0.0047
350 KLEBSIELLA INFECTION 24 0.0047
351 CYTOPENIA 58 0.0047
352 FEBRILE BONE MARROW APLASIA 20 0.0047
353 NEOPLASM PROGRESSION 163 0.0047
354 SUBDURAL HAEMATOMA 67 0.0047
355 NERVE INJURY 52 0.0047
356 OESOPHAGITIS 51 0.0047
357 PERIPHERAL VASCULAR DISORDER 24 0.0047
358 PAPILLOEDEMA 21 0.0046
359 RALES 27 0.0046
360 GINGIVAL PAIN 37 0.0046
361 HIP FRACTURE 149 0.0046
362 ESCHERICHIA INFECTION 38 0.0046
363 PULMONARY HYPERTENSION 96 0.0046
364 BLOOD LACTATE DEHYDROGENASE INCREASED 73 0.0046
365 HYPERLIPIDAEMIA 55 0.0046
366 BONE CANCER 20 0.0046
367 CONSTIPATION 1001 0.0046
368 DISEASE COMPLICATION 21 0.0046
369 RIB FRACTURE 94 0.0046
370 ONYCHOMYCOSIS 20 0.0046
371 ORAL CANDIDIASIS 60 0.0046
372 UROSEPSIS 42 0.0045
373 LABORATORY TEST ABNORMAL 134 0.0045
374 BLOOD CALCIUM DECREASED 51 0.0045
375 PHYSICAL DISABILITY 20 0.0045
376 PNEUMONITIS 123 0.0045
377 STAPHYLOCOCCAL INFECTION 149 0.0045
378 PLATELET COUNT DECREASED 480 0.0045
379 HEARING IMPAIRED 27 0.0045
380 OEDEMA 244 0.0045
381 THERAPY NON-RESPONDER 202 0.0045
382 CONJUNCTIVAL HAEMORRHAGE 17 0.0044
383 PERIPHERAL ISCHAEMIA 18 0.0044
384 HEPATIC LESION 19 0.0044
385 ABSCESS 70 0.0044
386 COAGULOPATHY 73 0.0044
387 ARTERIOSCLEROSIS CORONARY ARTERY 29 0.0044
388 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22 0.0043
389 BRADYCARDIA 230 0.0043
390 LEFT VENTRICULAR DYSFUNCTION 29 0.0043
391 PROSTATOMEGALY 17 0.0043
392 LEUKOPENIA 216 0.0043
393 TENDERNESS 45 0.0043
394 TOOTH DISORDER 96 0.0043
395 PROTEINURIA 82 0.0043
396 HERPES SIMPLEX 28 0.0043
397 HAEMODIALYSIS 36 0.0043
398 GENERAL PHYSICAL CONDITION ABNORMAL 29 0.0043
399 RHINITIS ALLERGIC 19 0.0043
400 METASTASES TO BONE 70 0.0043
401 DRUG TOXICITY 58 0.0043
402 AUTOIMMUNE THYROIDITIS 16 0.0042
403 DIALYSIS 60 0.0042
404 PULMONARY OEDEMA 188 0.0042
405 SCOLIOSIS 26 0.0042
406 PNEUMOCYSTIS JIROVECII PNEUMONIA 42 0.0042
407 RECURRENT CANCER 17 0.0042
408 EMPHYSEMA 42 0.0042
409 FAECAL INCONTINENCE 20 0.0042
410 MASS 58 0.0041
411 HYPERURICAEMIA 17 0.0041
412 METABOLIC DISORDER 24 0.0041
413 THROMBOTIC MICROANGIOPATHY 40 0.0041
414 ILEUS 51 0.0041
415 HYPOVOLAEMIA 24 0.0041
416 SINUS TACHYCARDIA 58 0.0041
417 CEREBRAL ATROPHY 16 0.0040
418 BLOOD UREA INCREASED 67 0.0040
419 INTESTINAL ISCHAEMIA 22 0.0040
420 CELLULITIS 201 0.0040
421 ORAL PAIN 89 0.0040
422 GENERALISED OEDEMA 49 0.0040
423 PULMONARY THROMBOSIS 43 0.0039
424 ATRIOVENTRICULAR BLOCK FIRST DEGREE 17 0.0039
425 ACUTE PULMONARY OEDEMA 22 0.0039
426 FLUID OVERLOAD 57 0.0039
427 NEOPLASM 45 0.0039
428 BLOOD CALCIUM INCREASED 34 0.0039
429 DIVERTICULITIS 107 0.0039
430 SKIN NECROSIS 20 0.0039
431 BLOOD CREATININE INCREASED 250 0.0038
432 REFUSAL OF TREATMENT BY PATIENT 25 0.0038
433 UPPER RESPIRATORY TRACT INFECTION 176 0.0038
434 BACTERIAL INFECTION 71 0.0038
435 BUNDLE BRANCH BLOCK LEFT 16 0.0038
436 NECROSIS 21 0.0038
437 RESPIRATORY TRACT INFECTION 98 0.0038
438 TOOTHACHE 68 0.0038
439 INTERVERTEBRAL DISC PROTRUSION 82 0.0037
440 ANGIOPATHY 21 0.0037
441 IMMUNE THROMBOCYTOPENIA 17 0.0037
442 FEMORAL NECK FRACTURE 19 0.0037
443 ISCHAEMIA 17 0.0037
444 SYNCOPE 370 0.0037
445 PERONEAL NERVE PALSY 21 0.0037
446 RENAL CELL CARCINOMA 18 0.0037
447 ADVERSE DRUG REACTION 329 0.0037
448 HEMIPARESIS 62 0.0037
449 ATRIAL FIBRILLATION 356 0.0037
450 ABASIA 90 0.0036
451 ACUTE RESPIRATORY FAILURE 70 0.0036
452 METASTASES TO LUNG 42 0.0036
453 NEUTROPHIL COUNT DECREASED 148 0.0036
454 HYPERKERATOSIS 20 0.0036
455 HEPATIC FAILURE 109 0.0036
456 ENCEPHALITIS 25 0.0036
457 BRONCHOPULMONARY ASPERGILLOSIS 28 0.0036
458 VASCULITIS 42 0.0036
459 PULMONARY FIBROSIS 69 0.0036
460 PNEUMONIA BACTERIAL 33 0.0036
461 ENTERITIS 23 0.0036
462 CARDIAC TAMPONADE 17 0.0036
463 RASH PUSTULAR 26 0.0036
464 PNEUMONIA ASPIRATION 89 0.0036
465 HIATUS HERNIA 46 0.0035
466 PERICARDIAL EFFUSION 82 0.0035
467 ATAXIA 42 0.0035
468 NEURALGIA 86 0.0035
469 CARDIOMYOPATHY 52 0.0035
470 MYOCARDIAL ISCHAEMIA 40 0.0035
471 CORONARY ARTERY DISEASE 106 0.0035
472 MULTIPLE ORGAN DYSFUNCTION SYNDROME 99 0.0035
473 PULMONARY CONGESTION 46 0.0035
474 SPINAL DISORDER 33 0.0035
475 SKIN LESION 95 0.0035
476 TOOTH FRACTURE 38 0.0034
477 HAEMORRHAGE INTRACRANIAL 51 0.0034
478 MOUTH HAEMORRHAGE 25 0.0034
479 COLITIS ISCHAEMIC 23 0.0034
480 PHARYNGITIS 42 0.0034
481 NEPHROPATHY TOXIC 38 0.0034
482 RASH MACULO-PAPULAR 75 0.0034
483 NEPHROTIC SYNDROME 23 0.0034
484 RENAL DISORDER 156 0.0033
485 GASTROINTESTINAL INFECTION 30 0.0033
486 SUPRAVENTRICULAR TACHYCARDIA 32 0.0033
487 BLOOD POTASSIUM INCREASED 54 0.0033
488 NORMAL NEWBORN 18 0.0033
489 HYPOAESTHESIA 495 0.0033
490 BONE PAIN 193 0.0033
491 SPINAL FRACTURE 66 0.0033
492 TRANSIENT ISCHAEMIC ATTACK 111 0.0033
493 COLON CANCER 49 0.0033
494 FAECALOMA 18 0.0033
495 MOUTH ULCERATION 69 0.0033
496 CARDIAC FAILURE 262 0.0033
497 DEHYDRATION 435 0.0033
498 WHITE BLOOD CELL COUNT DECREASED 351 0.0032
499 TACHYPNOEA 44 0.0032
500 HEPATOTOXICITY 72 0.0032
501 INTENTIONAL PRODUCT USE ISSUE 283 0.0032
502 RESPIRATORY SYNCYTIAL VIRUS INFECTION 28 0.0032
503 PHARYNGOLARYNGEAL PAIN 17 0.0032
504 RESPIRATORY DISTRESS 88 0.0032
505 IMMUNOSUPPRESSION 28 0.0032
506 MENINGITIS 21 0.0031
507 SKIN INFECTION 35 0.0031
508 CONVULSION 178 0.0031
509 HYPERCHOLESTEROLAEMIA 30 0.0031
510 MUSCULOSKELETAL CHEST PAIN 48 0.0031
511 GASTROINTESTINAL HAEMORRHAGE 259 0.0031
512 HYPOKALAEMIA 143 0.0031
513 CARDIAC DISORDER 288 0.0031
514 HAEMORRHOIDS 60 0.0031
515 METASTASES TO LIVER 54 0.0031
516 LYMPHOMA 47 0.0030
517 COLITIS 115 0.0030
518 GRAND MAL CONVULSION 28 0.0030
519 BLOOD SODIUM DECREASED 57 0.0030
520 HYPERKALAEMIA 106 0.0030
521 PULMONARY MASS 45 0.0030
522 HAEMOLYTIC ANAEMIA 27 0.0030
523 VENTRICULAR EXTRASYSTOLES 31 0.0030
524 ACUTE MYOCARDIAL INFARCTION 88 0.0030
525 INTERNATIONAL NORMALISED RATIO INCREASED 85 0.0030
526 ATRIOVENTRICULAR BLOCK 23 0.0030
527 ROTATOR CUFF SYNDROME 38 0.0030
528 HAEMOGLOBIN ABNORMAL 19 0.0030
529 BRAIN OEDEMA 37 0.0029
530 LUNG DISORDER 143 0.0029
531 PLATELET COUNT INCREASED 38 0.0029
532 DRUG INTOLERANCE 281 0.0029
533 HAEMOPTYSIS 81 0.0029
534 NEPHROPATHY 27 0.0029
535 CARDIAC MURMUR 25 0.0029
536 HEMIPLEGIA 24 0.0029
537 SKIN ULCER 74 0.0029
538 CARDIAC FAILURE ACUTE 19 0.0028
539 HYPOAESTHESIA ORAL 43 0.0028
540 PNEUMOTHORAX 45 0.0028
541 BLOOD COUNT ABNORMAL 43 0.0028
542 PULMONARY TOXICITY 20 0.0028
543 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 29 0.0028
544 GANGRENE 17 0.0028
545 NERVOUS SYSTEM DISORDER 88 0.0028
546 HAEMATURIA 96 0.0028
547 CYTOKINE RELEASE SYNDROME 56 0.0028
548 PYREXIA 961 0.0028
549 ASCITES 81 0.0028
550 RENAL IMPAIRMENT 230 0.0027
551 NEUTROPHIL COUNT INCREASED 28 0.0027
552 HYPOMAGNESAEMIA 38 0.0027
553 ASTHENIA 1024 0.0027
554 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 142 0.0027
555 BRAIN NEOPLASM 25 0.0027
556 PARAESTHESIA 424 0.0027
557 CARDIOVASCULAR DISORDER 68 0.0027
558 ARRHYTHMIA 126 0.0027
559 OSTEOARTHRITIS 112 0.0026
560 DISSEMINATED INTRAVASCULAR COAGULATION 37 0.0026
561 COVID-19 PNEUMONIA 31 0.0026
562 RED BLOOD CELL COUNT DECREASED 75 0.0026
563 ACIDOSIS 20 0.0026
564 SENSORY LOSS 21 0.0026
565 WHITE BLOOD CELL COUNT INCREASED 100 0.0026
566 MUSCLE ATROPHY 33 0.0026
567 TOOTH LOSS 54 0.0026
568 GASTROENTERITIS 38 0.0026
569 DYSPNOEA EXERTIONAL 98 0.0026
570 HYPERTRANSAMINASAEMIA 18 0.0026
571 TOXIC SKIN ERUPTION 26 0.0026
572 WALKING AID USER 17 0.0026
573 HYPOTENSION 516 0.0026
574 RIGHT VENTRICULAR FAILURE 18 0.0026
575 DEAFNESS 67 0.0026
576 FLANK PAIN 24 0.0026
577 INCONTINENCE 27 0.0026
578 EPISTAXIS 190 0.0025
579 ACUTE CORONARY SYNDROME 21 0.0025
580 RED BLOOD CELL SEDIMENTATION RATE INCREASED 28 0.0025
581 OSTEOPOROSIS 104 0.0025
582 HYPONATRAEMIA 142 0.0025
583 SLEEP APNOEA SYNDROME 48 0.0025
584 HEPATIC CIRRHOSIS 47 0.0025
585 URINARY INCONTINENCE 74 0.0025
586 DRUG RESISTANCE 64 0.0025
587 GINGIVAL BLEEDING 34 0.0025
588 AGRANULOCYTOSIS 46 0.0025
589 GASTRITIS 65 0.0025
590 CARDIOTOXICITY 22 0.0025
591 WOUND INFECTION 27 0.0025
592 APPENDICITIS 23 0.0025
593 HEPATOMEGALY 24 0.0024
594 CANDIDA INFECTION 41 0.0024
595 FOOT FRACTURE 46 0.0024
596 CARDIAC ARREST 200 0.0024
597 LOCAL SWELLING 42 0.0024
598 DEPRESSED LEVEL OF CONSCIOUSNESS 95 0.0024
599 HEPATOCELLULAR INJURY 34 0.0024
600 ADRENAL INSUFFICIENCY 29 0.0024
601 CARDIO-RESPIRATORY ARREST 99 0.0024
602 CEREBRAL HAEMORRHAGE 84 0.0023
603 PREGNANCY WITH CONTRACEPTIVE DEVICE 21 0.0023
604 INTERSTITIAL LUNG DISEASE 113 0.0023
605 LETHARGY 134 0.0023
606 ULCER 37 0.0023
607 LEUKOCYTOSIS 42 0.0023
608 HYPOTHYROIDISM 74 0.0023
609 HYPERBILIRUBINAEMIA 24 0.0023
610 FUNGAL INFECTION 77 0.0023
611 BURSITIS 28 0.0023
612 RESPIRATORY DISORDER 69 0.0023
613 SOMNOLENCE 461 0.0023
614 VISUAL ACUITY REDUCED 76 0.0023
615 GENERAL PHYSICAL HEALTH DETERIORATION 263 0.0023
616 FRACTURE 43 0.0023
617 HYDRONEPHROSIS 17 0.0023
618 PERITONITIS 47 0.0023
619 HAEMORRHAGE 237 0.0023
620 CHOLECYSTITIS 27 0.0023
621 PURPURA 20 0.0023
622 RENAL TUBULAR NECROSIS 22 0.0022
623 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 123 0.0022
624 FLUID RETENTION 114 0.0022
625 TOXIC EPIDERMAL NECROLYSIS 34 0.0022
626 VITAMIN D DECREASED 19 0.0022
627 TOXICITY TO VARIOUS AGENTS 374 0.0022
628 BRONCHITIS 164 0.0022
629 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 57 0.0022
630 LYMPHADENOPATHY 78 0.0022
631 IMMUNE SYSTEM DISORDER 29 0.0022
632 TOOTH INFECTION 29 0.0022
633 SMALL INTESTINAL OBSTRUCTION 27 0.0022
634 MYELOSUPPRESSION 79 0.0022
635 APHTHOUS ULCER 17 0.0022
636 LOCALISED INFECTION 53 0.0022
637 DEVICE RELATED INFECTION 33 0.0021
638 ERECTILE DYSFUNCTION 55 0.0021
639 BLOOD ALKALINE PHOSPHATASE INCREASED 53 0.0021
640 CATARACT 127 0.0021
641 CONFUSIONAL STATE 344 0.0021
642 ASPARTATE AMINOTRANSFERASE INCREASED 113 0.0021
643 LACERATION 20 0.0021
644 DIPLOPIA 55 0.0021
645 PETECHIAE 22 0.0021
646 OFF LABEL USE 1842 0.0021
647 SEDATION 55 0.0021
648 FEMUR FRACTURE 65 0.0021
649 SINUS DISORDER 41 0.0021
650 DIABETES MELLITUS 157 0.0021
651 APHASIA 62 0.0021
652 PRODUCT DISTRIBUTION ISSUE 19 0.0020
653 DELIRIUM 71 0.0020
654 BLOOD POTASSIUM DECREASED 61 0.0020
655 CARDIOGENIC SHOCK 29 0.0020
656 ADVERSE EVENT 184 0.0020
657 VENTRICULAR FIBRILLATION 22 0.0020
658 FALL 657 0.0020
659 WOUND 55 0.0020
660 CEREBROVASCULAR ACCIDENT 331 0.0020
661 SINUSITIS 200 0.0019
662 VITAMIN D DEFICIENCY 19 0.0019
663 LUNG NEOPLASM MALIGNANT 80 0.0019
664 URINE OUTPUT DECREASED 17 0.0019
665 PHOTOSENSITIVITY REACTION 32 0.0019
666 TREATMENT FAILURE 160 0.0019
667 HAEMATOMA 50 0.0019
668 SKIN DISORDER 64 0.0019
669 BODY TEMPERATURE INCREASED 39 0.0019
670 FACIAL PAIN 17 0.0019
671 C-REACTIVE PROTEIN INCREASED 69 0.0019
672 URINARY TRACT INFECTION 323 0.0019
673 CEREBRAL INFARCTION 46 0.0019
674 IMMUNODEFICIENCY 28 0.0019
675 LOWER LIMB FRACTURE 36 0.0019
676 EJECTION FRACTION DECREASED 29 0.0019
677 GASTROINTESTINAL DISORDER 167 0.0019
678 STOMATITIS 113 0.0019
679 MELAENA 41 0.0019
680 BONE LOSS 28 0.0019
681 UPPER LIMB FRACTURE 37 0.0019
682 LIVER FUNCTION TEST ABNORMAL 54 0.0019
683 BLOOD MAGNESIUM DECREASED 16 0.0019
684 INJURY 130 0.0018
685 CLOSTRIDIUM DIFFICILE INFECTION 40 0.0018
686 TREMOR 304 0.0018
687 ANHEDONIA 48 0.0018
688 ASPIRATION 20 0.0018
689 BEDRIDDEN 24 0.0018
690 CHOLESTASIS 35 0.0018
691 FATIGUE 1418 0.0018
692 CHEST PAIN 337 0.0018
693 VENTRICULAR TACHYCARDIA 30 0.0018
694 RECTAL HAEMORRHAGE 78 0.0018
695 BLOOD BILIRUBIN INCREASED 49 0.0018
696 DYSPHAGIA 172 0.0018
697 LYMPHOCYTE COUNT DECREASED 32 0.0018
698 ADVERSE REACTION 24 0.0018
699 GALLBLADDER DISORDER 32 0.0018
700 DISEASE RECURRENCE 85 0.0018
701 BODY HEIGHT DECREASED 19 0.0018
702 RASH GENERALISED 46 0.0018
703 SWELLING 166 0.0018
704 BALANCE DISORDER 153 0.0018
705 CHOLELITHIASIS 58 0.0018
706 HEPATIC FUNCTION ABNORMAL 66 0.0018
707 ACTIVITIES OF DAILY LIVING IMPAIRED 35 0.0018
708 DYSPNOEA 995 0.0018
709 UNRESPONSIVE TO STIMULI 45 0.0017
710 VIRAL INFECTION 58 0.0017
711 HEPATIC CYTOLYSIS 22 0.0017
712 INFLAMMATION 89 0.0017
713 TACHYCARDIA 153 0.0017
714 BACK PAIN 400 0.0017
715 COORDINATION ABNORMAL 24 0.0017
716 MYOCARDIAL INFARCTION 300 0.0017
717 POST PROCEDURAL COMPLICATION 33 0.0017
718 MUSCULAR WEAKNESS 195 0.0017
719 SPINAL PAIN 20 0.0017
720 HYPERTENSION 361 0.0017
721 SCAR 29 0.0017
722 SCIATICA 27 0.0017
723 CYST 21 0.0017
724 HYPOPHAGIA 43 0.0017
725 PERIPHERAL COLDNESS 23 0.0017
726 JAUNDICE 45 0.0017
727 DYSARTHRIA 62 0.0016
728 URINARY RETENTION 54 0.0016
729 GOUT 29 0.0016
730 NODULE 21 0.0016
731 ALANINE AMINOTRANSFERASE INCREASED 98 0.0016
732 ENCEPHALOPATHY 39 0.0016
733 DECREASED ACTIVITY 17 0.0016
734 STEVENS-JOHNSON SYNDROME 35 0.0016
735 MUSCULOSKELETAL DISCOMFORT 27 0.0016
736 RASH 683 0.0016
737 AGEUSIA 39 0.0016
738 HEPATITIS 40 0.0016
739 CONJUNCTIVITIS 29 0.0016
740 GLAUCOMA 30 0.0016
741 IMPAIRED GASTRIC EMPTYING 21 0.0015
742 INTESTINAL OBSTRUCTION 58 0.0015
743 BACK DISORDER 25 0.0015
744 SKIN CANCER 33 0.0015
745 OBSTRUCTIVE AIRWAYS DISORDER 17 0.0015
746 DIZZINESS 762 0.0015
747 SHOCK 35 0.0015
748 HYPOKINESIA 22 0.0015
749 MYOCLONUS 18 0.0015
750 OBESITY 24 0.0015
751 PERIPHERAL SWELLING 232 0.0015
752 MUSCULOSKELETAL PAIN 78 0.0015
753 RESPIRATORY ARREST 41 0.0015
754 UPPER GASTROINTESTINAL HAEMORRHAGE 25 0.0015
755 NEOPLASM MALIGNANT 98 0.0015
756 CIRCULATORY COLLAPSE 25 0.0015
757 ANGINA PECTORIS 42 0.0015
758 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 34 0.0015
759 TRANSAMINASES INCREASED 32 0.0014
760 HIP ARTHROPLASTY 22 0.0014
761 PRODUCT PRESCRIBING ISSUE 31 0.0014
762 GASTRIC ULCER 27 0.0014
763 NEPHROLITHIASIS 65 0.0014
764 NECK PAIN 79 0.0014
765 DIABETES MELLITUS INADEQUATE CONTROL 25 0.0014
766 SYSTEMIC LUPUS ERYTHEMATOSUS 50 0.0014
767 COMA 67 0.0014
768 PRODUCTIVE COUGH 67 0.0014
769 BRONCHOSPASM 20 0.0014
770 NOCTURIA 17 0.0014
771 PARALYSIS 20 0.0014
772 LIMB DISCOMFORT 43 0.0014
773 DERMATITIS 29 0.0014
774 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
775 CHILLS 162 0.0014
776 RASH ERYTHEMATOUS 66 0.0014
777 PANCREATITIS ACUTE 31 0.0014
778 LIVER DISORDER 61 0.0014
779 NIGHT SWEATS 44 0.0014
780 THYROID DISORDER 21 0.0014
781 ANKLE FRACTURE 21 0.0014
782 DRUG ERUPTION 24 0.0014
783 COVID-19 237 0.0013
784 METABOLIC ACIDOSIS 43 0.0013
785 DECREASED APPETITE 312 0.0013
786 LOSS OF CONSCIOUSNESS 172 0.0013
787 HEPATIC STEATOSIS 25 0.0013
788 LOWER RESPIRATORY TRACT INFECTION 61 0.0013
789 EAR PAIN 26 0.0013
790 DYSURIA 49 0.0013
791 DEMENTIA 37 0.0013
792 PAIN IN EXTREMITY 390 0.0013
793 ABDOMINAL DISTENSION 138 0.0013
794 PARAESTHESIA ORAL 19 0.0013
795 HEART RATE DECREASED 46 0.0013
796 PROSTATIC SPECIFIC ANTIGEN INCREASED 18 0.0013
797 FACE OEDEMA 22 0.0013
798 HAEMATEMESIS 33 0.0013
799 ARTHROPATHY 72 0.0013
800 DIARRHOEA 835 0.0013
801 VOMITING 607 0.0013
802 INFUSION RELATED REACTION 85 0.0013
803 TUBULOINTERSTITIAL NEPHRITIS 24 0.0013
804 DISTURBANCE IN ATTENTION 69 0.0013
805 SKIN REACTION 18 0.0013
806 EPILEPSY 39 0.0013
807 SWELLING FACE 83 0.0013
808 RASH PRURITIC 69 0.0013
809 SEASONAL ALLERGY 18 0.0013
810 PROSTATE CANCER 102 0.0013
811 MUSCLE SPASMS 232 0.0013
812 COGNITIVE DISORDER 59 0.0013
813 AMNESIA 82 0.0013
814 EOSINOPHILIA 22 0.0013
815 MENTAL IMPAIRMENT 30 0.0012
816 HYPOACUSIS 53 0.0012
817 GASTROOESOPHAGEAL REFLUX DISEASE 99 0.0012
818 PSYCHOTIC DISORDER 36 0.0012
819 BLOOD TEST ABNORMAL 17 0.0012
820 MOOD ALTERED 33 0.0012
821 RESTLESS LEGS SYNDROME 22 0.0012
822 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 86 0.0012
823 WEIGHT DECREASED 337 0.0012
824 GAIT DISTURBANCE 231 0.0012
825 HEAD INJURY 38 0.0012
826 TREATMENT NONCOMPLIANCE 65 0.0012
827 DISORIENTATION 47 0.0012
828 COUGH 330 0.0012
829 TINNITUS 54 0.0012
830 CONTUSION 113 0.0012
831 PULMONARY ARTERIAL HYPERTENSION 17 0.0012
832 THERAPEUTIC RESPONSE DECREASED 71 0.0012
833 ACUTE KIDNEY INJURY 179 0.0012
834 ARTHRITIS 92 0.0012
835 ABDOMINAL PAIN 272 0.0012
836 EYE DISORDER 38 0.0012
837 DRY MOUTH 93 0.0011
838 CYANOSIS 18 0.0011
839 JOINT SWELLING 138 0.0011
840 PERICARDITIS 19 0.0011
841 DYSPEPSIA 111 0.0011
842 JOINT INJURY 24 0.0011
843 SENSORY DISTURBANCE 18 0.0011
844 INFLUENZA 125 0.0011
845 HYPERSOMNIA 32 0.0011
846 MUSCULOSKELETAL DISORDER 21 0.0011
847 MENTAL DISORDER 48 0.0011
848 NAUSEA 868 0.0011
849 END STAGE RENAL DISEASE 20 0.0011
850 HYPOGLYCAEMIA 53 0.0011
851 AMENORRHOEA 19 0.0011
852 EATING DISORDER 23 0.0011
853 ISCHAEMIC STROKE 19 0.0011
854 DISABILITY 21 0.0011
855 PRODUCT USE IN UNAPPROVED INDICATION 262 0.0011
856 POLLAKIURIA 44 0.0011
857 EAR INFECTION 28 0.0011
858 BLOOD PRESSURE DECREASED 69 0.0010
859 HAEMATOCHEZIA 57 0.0010
860 VISION BLURRED 141 0.0010
861 DEPRESSION 231 0.0010
862 DYSGEUSIA 74 0.0010
863 JOINT STIFFNESS 26 0.0010
864 PAIN 607 0.0010
865 PARANOIA 17 0.0010
866 DISCOMFORT 60 0.0010
867 CONDITION AGGRAVATED 296 0.0010
868 VERTIGO 59 0.0010
869 LIMB INJURY 26 0.0010
870 BLINDNESS 39 0.0010
871 BLOOD URINE PRESENT 18 0.0009
872 FEELING JITTERY 18 0.0009
873 CYSTITIS 30 0.0009
874 DYSPHONIA 54 0.0009
875 SLEEP DISORDER 65 0.0009
876 SPEECH DISORDER 48 0.0009
877 INSOMNIA 242 0.0009
878 PRODUCT DOSE OMISSION 59 0.0009
879 LIVER INJURY 22 0.0009
880 RASH PAPULAR 20 0.0009
881 BLISTER 50 0.0009
882 DRUG INEFFECTIVE 1169 0.0009
883 HEART RATE IRREGULAR 20 0.0009
884 ANXIETY 247 0.0009
885 PRESYNCOPE 21 0.0009
886 WHEEZING 51 0.0009
887 DRUG EXPOSURE DURING PREGNANCY 29 0.0009
888 DRY EYE 42 0.0008
889 MALAISE 365 0.0008
890 CHEST DISCOMFORT 85 0.0008
891 FEELING COLD 23 0.0008
892 PANCREATITIS 43 0.0008
893 DRUG DOSE OMISSION 134 0.0008
894 PRODUCT USE ISSUE 151 0.0008
895 MEMORY IMPAIRMENT 110 0.0008
896 ARTHRALGIA 327 0.0008
897 MOBILITY DECREASED 56 0.0008
898 WEIGHT INCREASED 174 0.0008
899 RENAL INJURY 23 0.0008
900 RHINORRHOEA 50 0.0008
901 DRY SKIN 103 0.0008
902 BURNING SENSATION 54 0.0008
903 NERVOUSNESS 40 0.0008
904 OXYGEN SATURATION DECREASED 43 0.0008
905 HYPERSENSITIVITY 142 0.0008
906 ROAD TRAFFIC ACCIDENT 32 0.0008
907 PALPITATIONS 88 0.0008
908 GAIT INABILITY 25 0.0007
909 TYPE 2 DIABETES MELLITUS 25 0.0007
910 MYALGIA 126 0.0007
911 FEELING ABNORMAL 177 0.0007
912 ALTERED STATE OF CONSCIOUSNESS 16 0.0007
913 PALLOR 20 0.0007
914 GASTRIC DISORDER 25 0.0007
915 OROPHARYNGEAL PAIN 67 0.0007
916 SKIN EXFOLIATION 61 0.0007
917 HOSPITALISATION 111 0.0007
918 DYSSTASIA 21 0.0007
919 SKIN DISCOLOURATION 32 0.0007
920 RHABDOMYOLYSIS 29 0.0007
921 HALLUCINATION 52 0.0007
922 ERYTHEMA 141 0.0007
923 THERAPY INTERRUPTED 49 0.0007
924 ABDOMINAL PAIN UPPER 141 0.0007
925 NASOPHARYNGITIS 126 0.0007
926 HYPERHIDROSIS 88 0.0007
927 HEART RATE INCREASED 67 0.0007
928 AGITATION 49 0.0007
929 BLOOD PRESSURE FLUCTUATION 16 0.0007
930 NASAL CONGESTION 39 0.0007
931 VISUAL IMPAIRMENT 82 0.0007
932 HEPATIC ENZYME INCREASED 45 0.0007
933 MOOD SWINGS 21 0.0007
934 SWOLLEN TONGUE 20 0.0006
935 DRUG INTERACTION 101 0.0006
936 RASH MACULAR 22 0.0006
937 LACRIMATION INCREASED 19 0.0006
938 ASTHMA 71 0.0006
939 SEIZURE 71 0.0006
940 BLOOD GLUCOSE INCREASED 115 0.0006
941 PRODUCT DOSE OMISSION ISSUE 178 0.0006
942 HEADACHE 377 0.0006
943 ANAPHYLACTIC REACTION 33 0.0006
944 SURGERY 35 0.0006
945 BLOOD PRESSURE INCREASED 91 0.0006
946 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
947 BREAST CANCER 54 0.0006
948 DEPRESSED MOOD 30 0.0006
949 MOVEMENT DISORDER 18 0.0006
950 EYE PAIN 31 0.0005
951 FLATULENCE 30 0.0005
952 ILL-DEFINED DISORDER 32 0.0005
953 LACTIC ACIDOSIS 17 0.0005
954 BLOOD GLUCOSE DECREASED 25 0.0005
955 ALOPECIA 102 0.0005
956 RESTLESSNESS 19 0.0005
957 DYSKINESIA 21 0.0005
958 BLOOD CHOLESTEROL INCREASED 24 0.0005
959 EMOTIONAL DISTRESS 62 0.0005
960 EYE SWELLING 19 0.0005
961 LIP SWELLING 17 0.0005
962 MUSCULOSKELETAL STIFFNESS 43 0.0005
963 INFLUENZA LIKE ILLNESS 39 0.0005
964 PRURITUS 182 0.0005
965 PANIC ATTACK 17 0.0005
966 DRUG EFFECT DECREASED 25 0.0005
967 BLADDER CANCER 27 0.0005
968 EXPOSURE DURING PREGNANCY 28 0.0005
969 CHRONIC KIDNEY DISEASE 34 0.0004
970 SUICIDAL IDEATION 40 0.0004
971 ABDOMINAL DISCOMFORT 73 0.0004
972 URTICARIA 72 0.0004
973 ABNORMAL BEHAVIOUR 16 0.0004
974 OCULAR HYPERAEMIA 19 0.0004
975 ECZEMA 20 0.0004
976 HOT FLUSH 28 0.0004
977 FEELING HOT 21 0.0003
978 ILLNESS 35 0.0003
979 IRRITABILITY 19 0.0003
980 MEDICATION ERROR 17 0.0003
981 SUICIDE ATTEMPT 18 0.0003
982 ACNE 22 0.0003
983 FLUSHING 25 0.0002
984 RHEUMATOID ARTHRITIS 27 0.0002
985 PSORIASIS 27 0.0002
986 MATERNAL EXPOSURE DURING PREGNANCY 18 0.0002
987 MIGRAINE 19 0.0002
988 INTENTIONAL PRODUCT MISUSE 17 0.0002
989 DRUG DEPENDENCE 24 0.0001
990 OVERDOSE 31 0.0001
991 NO ADVERSE EVENT 24 0.0001
992 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 22 0.0001